Can a patient with panic attacks remain on bupropion 150 mg while increasing escitalopram from 15 mg to 20 mg, given she also uses as‑needed alprazolam?

Yes, it is acceptable to keep bupropion 150 mg while increasing escitalopram from 15 mg to 20 mg in this patient with panic attacks

Your patient can safely continue bupropion 150 mg while you increase escitalopram to 20 mg, though you should monitor closely for anxiety worsening during the first 2-4 weeks. While bupropion has historically been viewed with caution in panic disorder due to its activating properties, recent evidence and clinical experience suggest it can be tolerated when combined with an SSRI, particularly at the lower dose your patient is taking.

Evidence Supporting This Approach

SSRIs as First-Line for Panic Disorder

Escitalopram is well-established as effective first-line treatment for panic disorder. Multiple studies demonstrate that escitalopram 10-20 mg/day significantly reduces panic attack frequency and severity 1, 2, 3. Increasing to 20 mg is appropriate and supported by evidence showing this dose range provides optimal efficacy for anxiety disorders 4.

Bupropion's Complex Role in Anxiety

The concern about bupropion in panic disorder stems from older clinical lore, but newer data paint a more nuanced picture:

• Bupropion can reduce anxiety symptoms in patients with comorbid depression and anxiety, showing comparable efficacy to SSRIs/SNRIs for mild-to-moderate anxiety 5
• One open-label study specifically in panic disorder showed bupropion SR produced clinically significant reductions in panic symptoms, with mean CGI improvement of 1-2 points 6
• However, bupropion's stimulating properties can provoke anxiety, particularly at higher doses 5
• Guidelines note bupropion "should not be used in agitated patients" 7, though this refers primarily to severe agitation

The Combination Strategy

The combination of escitalopram and bupropion is commonly used and well-tolerated in clinical practice 8. In an open trial of this specific combination for depression:

• Response rate: 62%
• Remission rate: 50%
• Only 6% discontinued due to side effects
• Mean doses: escitalopram 18 mg/day, bupropion SR 327 mg/day 8

Your patient is already tolerating this combination at lower doses (escitalopram 15 mg, bupropion 150 mg), which suggests good tolerability.

Clinical Reasoning for Your Situation

The key factors favoring continuation of bupropion:

1. Current tolerance: She's already on bupropion 150 mg without apparent worsening of panic symptoms
2. Low dose: 150 mg is the starting dose and well below the maximum 400 mg/day 7
3. Patient preference: Respecting her autonomy when the risk is manageable
4. Potential benefits: Bupropion may be addressing comorbid depression, low energy, or other symptoms
5. PRN benzodiazepine coverage: Alprazolam provides a safety net for breakthrough anxiety 9, 10

Monitoring Plan

During the first 2-4 weeks after increasing escitalopram:

• Watch for increased anxiety, agitation, or panic attack frequency 4, 11
• SSRIs can initially cause anxiety/agitation as a side effect 4
• Assess whether alprazolam use increases
• If anxiety worsens significantly, then discontinue bupropion

Important safety considerations:

• Monitor for serotonin syndrome when combining serotonergic agents, though risk is low with this combination 4
• Escitalopram has minimal CYP450 interactions compared to other SSRIs 4
• Avoid abrupt discontinuation of either medication 11
• The bupropion dose is well below seizure-risk threshold 12, 11

When to Reconsider Bupropion

You should discontinue bupropion if:

• Panic attacks increase in frequency or severity
• New or worsening agitation, insomnia, or anxiety emerges
• Patient requires escalating alprazolam use
• She develops signs of activation (restlessness, pressured speech, decreased sleep need)

Regarding the Alprazolam

The PRN alprazolam is appropriate for breakthrough symptoms 13, 10. However, avoid regular scheduled benzodiazepine use long-term despite their efficacy in panic disorder 14, 2. The goal is SSRI monotherapy (or SSRI + bupropion if tolerated) with only occasional benzodiazepine rescue.

Bottom Line

Proceed with increasing escitalopram to 20 mg while continuing bupropion 150 mg, with close monitoring over the next month. This respects your patient's preference while maintaining safety. If panic symptoms worsen, you can always discontinue the bupropion at that point—but given her current tolerance and the low dose, there's reasonable evidence this combination can work.